USP28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.555400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.422000E-02
Normal-vs-Stage2
4.919500E-03
Normal-vs-Stage3
1.148390E-01
Normal-vs-Stage4
2.305200E-01
Stage1-vs-Stage2
7.627000E-01
Stage1-vs-Stage3
7.432100E-02
Stage1-vs-Stage4
8.125800E-01
Stage2-vs-Stage3
6.36629999999361E-05
Stage2-vs-Stage4
9.029800E-01
Stage3-vs-Stage4
1.805820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.395600E-03
Normal-vs-AfricanAmerican
1.476620E-01
Normal-vs-Asian
1.432300E-02
Caucasian-vs-AfricanAmerican
4.627200E-01
Caucasian-vs-Asian
3.961800E-01
AfricanAmerican-vs-Asian
2.369800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.252600E-01
Normal-vs-Female
8.598300E-03
Male-vs-Female
6.117400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.145590E-01
Normal-vs-Age(41-60Yrs)
2.565600E-02
Normal-vs-Age(61-80Yrs)
8.027700E-04
Normal-vs-Age(81-100Yrs)
3.082000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.290800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.727200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.449600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.221800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.315640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.782800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.504190E-02
Normal-vs-Daily Drinker
1.894040E-02
Normal-vs-Weekly Drinker
1.223950E-02
Normal-vs-Occasional Drinker
2.061000E-01
Normal-vs-Social Drinker
7.745700E-02
Non Drinker-vs-Daily Drinker
7.658600E-01
Non Drinker-vs-Weekly Drinker
8.055000E-01
Non Drinker-vs-Occasional Drinker
6.950600E-01
Non Drinker-vs-Social Drinker
2.415800E-01
Daily Drinker-vs-Weekly Drinker
9.741000E-01
Daily Drinker-vs-Occasional Drinker
9.478600E-01
Daily Drinker-vs-Social Drinker
1.865160E-01
Weekly Drinker-vs-Occasional Drinker
9.113800E-01
Weekly Drinker-vs-Social Drinker
1.848200E-01
Occasional Drinker-vs-Social Drinker
9.980000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.282400E-01
Normal-vs-Grade 2
8.046000E-01
Normal-vs-Grade 3
2.956400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.294100E-02
Grade 1-vs-Grade 3
5.203600E-03
Grade 1-vs-Grade 4
9.282400E-01
Grade 2-vs-Grade 3
5.288300E-02
Grade 2-vs-Grade 4
8.046000E-01
Grade 3-vs-Grade 4
2.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.206000E-01
Normal-vs-NonDiabetic
1.921020E-03
Diabetic-vs-NonDiabetic
9.657200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.400630E-01
Normal-vs-NoPancreatitis
9.237000E-04
Pancreatitis-vs-NoPancreatitis
8.987800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.901300E-03
Normal-vs-N1
3.260600E-03
N0-vs-N1
3.111800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.668200E-01
Normal-vs-TP53-NonMutant
3.097600E-01
TP53-Mutant-vs-TP53-NonMutant
2.754400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
